Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Elena Vega

EXPLAINED: Repatha linked to 20 lower heart attack rate than ezetimibe in 544 000 patient study - The Real Truth

Adults with heart disease who started the cholesterol injection Repatha had a 20% lower rate of heart attacks than similar patients who started the pill ezetimibe, in a study of 544,103 U.S. patients published in the American Journal of Preventive Cardiology. The hazard ratio for fatal or nonfatal heart attack was 0.80, according to an Amgen announcement Nov. 5.

In absolute terms, the difference was smaller. Among patients with a recorded starting LDL cholesterol level, the estimated four-year risk of heart attack was 5.88% with Repatha and 7.76% with ezetimibe, a gap of about 1.9 percentage points.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.